Bim is upregulated in a Foxo- or JNK-dependent manner following status epilepticus, and has been shown to co-immunoprecipitate with anti-apoptotic Bcl-2 family proteins, suggesting it is active (Shinoda et al., 2004; Murphy et al., 2010). Here, BCL2 is linked to status epilepticus.